Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Fazeli, Mir Sohail; Khaychuk, Vadim; Wittstock, Keith; Breznen, Boris; Crocket, Grace; Pourrahmat, Mir-Masoud; Ferri, Leticia

Fazeli, Mir Sohail; Khaychuk, Vadim; Wittstock, Keith; Breznen, Boris; Crocket, Grace; Pourrahmat, Mir-Masoud; Ferri, Leticia.

Afiliación

Fazeli MS; Evidinno Outcomes Research Inc., Vancouver, BC, Canada.
Khaychuk V; Bristol Myers Squibb, Princeton, NJ, USA.
Wittstock K; Bristol Myers Squibb, Princeton, NJ, USA.
Breznen B; Evidinno Outcomes Research Inc., Vancouver, BC, Canada.
Crocket G; Bristol Myers Squibb, Princeton, NJ, USA.
Pourrahmat MM; Joulé Inc., Edison, NJ, USA.
Ferri L; Evidinno Outcomes Research Inc., Vancouver, BC, Canada.

Clin Med Insights Arthritis Musculoskelet Disord ; 14: 11795441211028751, 2021.

Article en En | MEDLINE | ID: mdl-34262386

Palabras clave

Rheumatoid Arthritis; autoantibodies; cardiovascular diseases; disease modifying antirheumatic drugs; risk factors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Clin Med Insights Arthritis Musculoskelet Disord Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google